The report highlights that a hydrogel-based delivery system introduced in 2024 may allow semaglutide administration only once per month instead of weekly injections
We recommend avoiding weight loss injections if you have: Medullary thyroid carcinoma Multiple endocrine neoplasia type 2 Pancreatitis Gastrointestinal disease Type 1 diabetes Are pregnant or breastfeeding Severe depression Your physician at The Well Westlake will help you determine if you are a good candidate for weight loss injections during your initial consultation
Requires medical supervision : Youll need to see your doctor regularly to monitor effectiveness and side effects
Ideal candidates for semaglutide include: Adults with type 2 diabetes (Ozempic and Rybelsus) Adults who have established heart and blood vessel-related disease or those who are at risk of developing these diseases or heart failure (Ozempic) Adults with chronic kidney disease and type 2 diabetes, to reduce the risk of worsening kidney disease or end-stage renal disease (Ozempic) Children aged 12 or more, adolescents, and adults with obesity (BMI 30 or more) and overweight (BMI 27 or more) with at least one weight-related complication, such as hypercholesterolemia, hyperlipidemia, heart disease, and hypertension (Wegovy) Patients with metabolic dysfunction-associated steatohepatitis (MASH) in adults with moderate to advanced liver scarring or fibrosis, but they should not have cirrhosis (Wegovy) Head-to-head comparison: Metformin vs
In conclusion, the addition of semaglutide injections to lifestyle and metformin interventions can reduce BMI, waist and hip circumference, and body fat percentage, alleviate hyperandrogenemia, improve glucose metabolism and insulin resistance, and promote the restoration of normal menstrual cycles without exacerbating negative psychological emotions in individuals living with overweight/obesity and PCOS-related infertility
